Page last updated: 2024-09-05

cilengitide and Cirrhosis, Liver

cilengitide has been researched along with Cirrhosis, Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodman, SL; Ledermann, M; Niedobitek, G; Patsenker, E; Popov, Y; Sägesser, H; Schneider, V; Schuppan, D; Stickel, F1

Other Studies

1 other study(ies) available for cilengitide and Cirrhosis, Liver

ArticleYear
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:5

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Movement; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; gamma-Glutamyltransferase; Hepatic Stellate Cells; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin alphaVbeta3; Ligation; Liver; Liver Cirrhosis; Male; Neovascularization, Physiologic; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Snake Venoms; Thioacetamide

2009